Qardio RPM includes cardiac monitoring

  • September 21, 2021
  • Steve Rogerson

California-based Qardio has launched a fully remote end-to-end remote patient monitoring (RPM) service that includes cardiac arrhythmia analysis.

QardioDirect – the company’s all-inclusive service for RPM – now includes ambulatory cardiac monitoring to help diagnose atrial fibrillation along with a large range of other arrhythmias. Multiple short-duration recordings can identify symptomatic and asymptomatic periods of cardiac activity. Then, as a more detailed analysis is needed, a full 24 to 48 hours Holter analysis can be prescribed with rapid turnaround and reporting.

QardioDirect is said to empower clinicians to manage a full range of cardiovascular conditions in a fast, accurate and scalable way.

The QardioCore Holter monitor is a patient-friendly device. No skin preparation is needed, there are no gels, no patches and no wires, which increases patient comfort. This helps ensure high patient compliance and high diagnostic yields, which results in better patient outcomes.

QardioDirect user George Fahnbulleh from Gold Canyon Internal Medicine in Arizona said: “Thanks to Qardio, we’ve been able to catch at least three patients who had heart arrhythmias. We were then able to send them immediately to a cardiologist. The benefits of using QardioDirect are phenomenal.”

Qardio’s co-founder Rosario Iannella said: “Qardio’s history of innovation continues as we launch RPM and Holter analysis services in a single, unified workflow. QardioDirect is the only platform that enables practitioners to remotely identify changes in the patient baselines across multiple key vital signs and also diagnose a wide range of cardiac arrhythmias.”

Qardio is a medical technology company that operates at the intersection of cardiology and remote monitoring. Its products provide improved outcomes for care providers and their patients across a range of care modalities via improved workflows and diagnostic yields, reduced cost and ease of use.

Founded in 2012, Qardio’s primary mission is to improve outcomes for adults living with a chronic heart condition through simplified monitoring and diagnosis. QardioDirect, the remote patient monitoring service, is equally suited to primary care and to discrete applications in hypertension, cardiovascular disease, obesity, chronic kidney disease, diabetes, post-surgical care and other chronic care conditions.